Back to top

Analyst Blog

Isis Pharmaceuticals, Inc. (ISIS - Analyst Report) was a big mover last session, as the company saw its shares move higher by over 14% on the day. The move came on the back of solid volume too, as far more shares changed hands than in a normal session. The uptrend is continuing for this biotechnology company, as the stock surged more than 40% in the past one-month time period.

The company has seen 5 positive revisions in the past few weeks and its earnings consensus has moved up over the past two months, suggesting that more solid trading could be ahead for ISIS. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Isis Pharmaceuticals currently has a Zacks Rank #3 (Hold) and its Earnings ESP is positive.

Some better performing biotechnology stocks include Affymetrix Inc. (AFFX - Analyst Report), Biogen Idec Inc. (BIIB - Analyst Report) and Gilead Sciences Inc. (GILD - Analyst Report). All these carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Please login to Zacks.com or register to post a comment.